Received Feb 13, 2025
| Type | Name | Manufacturer | Dose | Lot | Route / Site |
|---|---|---|---|---|---|
| FLU3 | INFLUENZA (SEASONAL) (FLULAVAL) | GLAXOSMITHKLINE BIOLOGICALS | UNK | Z29D3 | IM / LA |
Patient complaint of reaction post vaccination. Patient scheduled with provider visit on 02-04-2025, patient reports she believes staff caused lesion and per patient reports she noted day 1 post vaccination area appeared swollen, beefy raw and reported discomfort. Patient denies previous allergic reaction to vaccines. Upon assessment of affected area, area appeared swollen, moderate erythema surrounding affected area and wound bed appeared discolored/ dry blood (scab like), patient denied fever or drainage to wound and wound measured 1,5inx1.5in. Assessed patient for allergic reaction: high persistent fever, angioedema, pruritus, SOB, hives , swelling or redness to injection site, patient reported only discomfort/ swelling and redness. Wound assessed by provider per provider wound care done, applied triple antibiotic and instructed patient to cover wound. Affected area marked and informed patient if erythema surpasses line, patient to go to ER. Patient verbalized understanding. Patient has been visiting nursing for wound care and monitoring of wound. Wound appears to be healing with 80% improvement, measuring 0.5inx0.5in, no erythema or swelling to affected site and healthy granulation tissue present with no drainage to area at this time. Patient scheduled for wound check in one week with nursing per provider.
primary osteoarthritis, elevated lipids and generalized pruritus
primary osteoarthritis and elevated lipids
active medications list: atorvastatin, triamcinolone acetonide 0.025% topical cream, Vitamin C and Ferrous Sulfate; However OTC/ dietary supplements or herbal remedies at the time of vaccination unknown.
no known allergies
n/a